1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Long QT syndrome type 3: new trials by email Literature Review of Long QT syndrome type 3 trials Research Report on Long QT syndrome type 3
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Long Term Prophylactic Therapy of Congenital Long QT Syndrome Type III (LQT3) With Ranolazine Ranolazine - Long QT Syndrome Type 3 | Phase 2 | Unknown | Tel-Aviv Sourasky Medical Center | 10 | 2012-10-01 | 2015-03-26 |
Long QT Syndrome (1)
Arrhythmias, Cardiac (1) · Cardiac Conduction System Disease (1) · Cardiovascular Abnormalities (1) · Cardiovascular Diseases (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Heart Defects, Congenital (1) · Heart Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Ranolazine (1)
Tel-Aviv Sourasky Medical Center (1)
Israel (1)